EC 1.17.4.1 (ribonucleoside-diphosphate reductase) inhibitor

Term ID

CHEBI:74213

Synonyms

2'-deoxyribonucleoside-diphosphate:thioredoxin-disulfide 2'-oxidoreductase inhibitor
2'-deoxyribonucleoside-diphosphate:thioredoxin-disulfide 2'-oxidoreductase inhibitors
ADP reductase inhibitor
ADP reductase inhibitors
CDP reductase inhibitor
CDP reductase inhibitors
EC 1.17.4.1 (ribonucleoside-diphosphate reductase) inhibitors
EC 1.17.4.1 inhibitor
EC 1.17.4.1 inhibitors
nucleoside diphosphate reductase inhibitor
nucleoside diphosphate reductase inhibitors
ribonucleoside diphosphate reductase inhibitor
ribonucleoside diphosphate reductase inhibitors
ribonucleoside-diphosphate reductase (EC 1.17.4.1) inhibitor
ribonucleoside-diphosphate reductase (EC 1.17.4.1) inhibitors
ribonucleoside-diphosphate reductase inhibitor
ribonucleoside-diphosphate reductase inhibitors
ribonucleotide diphosphate reductase inhibitor
ribonucleotide diphosphate reductase inhibitors
ribonucleotide reductase inhibitor
ribonucleotide reductase inhibitors
RR inhibitor
RR inhibitors
UDP reductase inhibitor
UDP reductase inhibitors

Definition

An EC 1.17.* (oxidoreductase acting on CH or CH2) inhibitor that inhibits the action of ribonucleoside-diphosphate reductase (EC 1.17.4.1).

References

Ontology

ChEBI ( EBI )

Relationships

is a type of: EC 1.17.4.* (oxidoreductase acting on CH or CH2 with a disulfide as acceptor) inhibitor

EC 1.17.4.* (oxidoreductase acting on CH or CH2 with a disulfide as acceptor) inhibitor Show first 5 Terms
inverse has_role: gemcitabine gemcitabine hydrochloride guanazole hydroxyurea triapine

gemcitabine gemcitabine hydrochloride guanazole hydroxyurea triapine Show first 5 Terms

Phenotype

Phenotype resulting from EC 1.17.4.1 (ribonucleoside-diphosphate reductase) inhibitor

Phenotype where environments contain EC 1.17.4.1 (ribonucleoside-diphosphate reductase) inhibitor

Phenotype modified by environments containing EC 1.17.4.1 (ribonucleoside-diphosphate reductase) inhibitor

Human Disease Model